Host-pathogen interactions - Inhibition of PP1 phosphatase activity by HBx: A mechanism for the activation of hepatitis B virus transcription

Science Signaling

Volumn 5, Issue 205, 2012, Pages

  Cougot, Delphine ^a,b,c   Allemand, Eric ^a   Rivière, Lise ^a,b   Benhenda, Shirine ^a,b,d   Duroure, Karine ^a,b   Levillayer, Florence ^a,b   Muchardt, Christian ^a   Buendia, Marie Annick ^a,b   Neuveut, Christine ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HEPATITIS B VIRUS X PROTEIN; HISTONE DEACETYLASE 1; PHOSPHOPROTEIN PHOSPHATASE 1; TRANSCRIPTION FACTOR; VIRUS DNA; FORSKOLIN; PRIMER DNA; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ARTICLE; ENZYME ACTIVITY; GENOME; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; IN VIVO STUDY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; VIRUS ACTIVATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANALYSIS OF VARIANCE; BIOLOGICAL MODEL; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; DRUG ANTAGONISM; GEL CHROMATOGRAPHY; GENETICS; HELA CELL; HUMAN; METABOLISM; NORTHERN BLOTTING; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

HEPATITIS B VIRUS;

ANALYSIS OF VARIANCE; BLOTTING, NORTHERN; CHROMATIN IMMUNOPRECIPITATION; CHROMATOGRAPHY, GEL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA PRIMERS; DNA, VIRAL; FORSKOLIN; HEK293 CELLS; HELA CELLS; HEPATITIS B VIRUS; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84855368016     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2001906     Document Type: Article

References (66)

1. D. Ganem, in Fields Virology, B. Fields, D. Knipe, P. Howley, Eds. (Lippincott-Raven, Philadelphia, 1996), pp. 2703-2737.
2. T. J. Liang, Hepatitis B: The virus and disease. Hepatology 49, S13-S21 (2009).
3. N. Moolla, M. Kew, P. Arbuthnot, Regulatory elements of hepatitis B virus transcription. J. Viral Hepat. 9, 323-331 (2002).
4. S. Buhlmann, T. Racek, A. Schwarz, S. Schaefer, B. M. Putzer, Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: Implications for hepatocarcinogenesis. J. Mol. Biol. 378, 20-30 (2008).
5. M. Quasdorff, M. Hosel, M. Odenthal, U. Zedler, F. Bohne, P. Gripon, H. P. Dienes, U. Drebber, D. Stippel, T. Goeser, U. Protzer, A concerted action of HNF4α and HNF1α links hepatitis B virus replication to hepatocyte differentiation. Cell. Microbiol. 10, 1478-1490 (2008).
6. L. Belloni, T. Pollicino, F. De Nicola, F. Guerrieri, G. Raffa, M. Fanciulli, G. Raimondo, M. Levrero, Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc. Natl. Acad. Sci. U.S.A. 106, 19975-19979 (2009).
7. T. Pollicino, L. Belloni, G. Raffa, N. Pediconi, G. Squadrito, G. Raimondo, M. Levrero, Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 130, 823-837 (2006).
8. S. Benhenda, D. Cougot, M. A. Buendia, C. Neuveut, Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv. Cancer Res. 103, 75-109 (2009).
9. H. S. Chen, S. Kanako, R. Girones, R. W. Anderson, W. E. Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, R. H. Miller, The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67, 1218-1226 (1993).
10. V. V. Keasler, A. J. Hodgson, C. R. Madden, B. L. Slagle, Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J. Virol. 81, 2656-2662 (2007).
11. M. Melegari, P. P. Scaglioni, J. R. Wands, Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J. Virol. 72, 1737-1743 (1998).
12. F. Zoulim, J. Saputelli, C. Seeger, Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68, 2026-2030 (1994).
13. Y. C. Chou, K. S. Jeng, M. L. Chen, H. H. Liu, T. L. Liu, Y. L. Chen, Y. C. Liu, C. P. Hu, C. Chang, Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J. Virol. 79, 1813-1823 (2005).
14. H. Tang, L. Delgermaa, F. Huang, N. Oishi, L. Liu, F. He, L. Zhao, S. Murakami, The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J. Virol. 79, 5548-5556 (2005).
15. D. Cougot, Y. Wu, S. Cairo, J. Caramel, C. A. Renard, L. Levy, M. A. Buendia, C. Neuveut, The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J. Biol. Chem. 282, 4277-4287 (2007).
16. G. Servillo, M. A. Della Fazia, P. Sassone-Corsi, Coupling cAMP signaling to transcription in the liver: Pivotal role of CREB and CREM. Exp. Cell Res. 275, 143-154 (2002).
17. B. Mayr, M. Montminy, Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599-609 (2001).
18. M. Hagiwara, A. Alberts, P. Brindle, J. Meinkoth, J. Feramisco, T. Deng, M. Karin, S. Shenolikar, M. Montminy, Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell 70, 105-113 (1992).
19. B. E. Wadzinski, W. H. Wheat, S. Jaspers, L. F. Peruski Jr., R. L. Lickteig, G. L. Johnson, D. J. Klemm, Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol. Cell. Biol. 13, 2822-2834 (1993).
20. G. Canettieri, I. Morantte, E. Guzman, H. Asahara, S. Herzig, S. D. Anderson, J. R. Yates III, M. Montminy, Attenuation of a phosphorylation- dependent activator by an HDAC-PP1 complex. Nat. Struct. Biol. 10, 175-181 (2003).
21. G. B. Moorhead, L. Trinkle-Mulcahy, M. Nimick, V. DeWever, D. G. Campbell, R. Gourlay, Y. W. Lam, A. I. Lamond, Displacement affinity chromatography of protein phosphatase one (PP1) complexes. BMC Biochem. 9, 28 (2008).
22. S. K. Ladner, M. J. Otto, C. S. Barker, K. Zaifert, G. H. Wang, J. T. Guo, C. Seeger, R. W. King, Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41, 1715-1720 (1997).
23. F. Tacke, C. Liedtke, S. Bocklage, M. P. Manns, C. Trautwein, CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 54, 1309-1317 (2005).
24. T. Zhou, H. Guo, J. T. Guo, A. Cuconati, A. Mehta, T. M. Block, Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays. Antiviral Res. 72, 116-124 (2006).
25. R. W. King, S. K. Ladner, T. J. Miller, K. Zaifert, R. B. Perni, S. C. Conway, M. J. Otto, Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)β-L-2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 42, 3179-3186 (1998).
26. J. S. Williams, O. M. Andrisani, The hepatitis B virus X protein targets the basic region - leucine zipper domain of CREB. Proc. Natl. Acad. Sci. U.S.A. 92, 3819-3823 (1995).
27. M. J. Yin, R. B. Gaynor, HTLV-1 21 bp repeat sequences facilitate stable association between Tax and CREB to increase CREB binding affinity. J. Mol. Biol. 264, 20-31 (1996).
28. I. Bar-Yishay, Y. Shaul, A. Shlomai, Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int. 31, 282-290 (2011).
29. B. K. Kim, S. O. Lim, Y. G. Park, Requirement of the cyclic adenosine monophosphate response element-binding protein for hepatitis B virus replication. Hepatology 48, 361-373 (2008).
30. L. F. Michael, H. Asahara, A. I. Shulman, W. L. Kraus, M. Montminy, The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism. Mol. Cell. Biol. 20, 1596-1603 (2000).
31. J. K. Shon, B. H. Shon, I. Y. Park, S. U. Lee, L. Fa, K. Y. Chang, J. H. Shin, Y. I. Lee, Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription. Virus Res. 139, 14-21 (2009).
32. H. F. Maguire, J. P. Hoeffler, A. Siddiqui, HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252, 842-844 (1991).
33. H. Ceulemans, M. Bollen, Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84, 1-39 (2004).
34. D. M. Virshup, S. Shenolikar, From promiscuity to precision: Protein phosphatases get a makeover. Mol. Cell 33, 537-545 (2009).
35. P. T. Cohen, Protein phosphatase 1 - Targeted in many directions. J. Cell Sci. 115, 241-256 (2002).
36. A. Hendrickx, M. Beullens, H. Ceulemans, T. Den Abt, A. Van Eynde, E. Nicolaescu, B. Lesage, M. Bollen, Docking motif-guided mapping of the interactome of protein phosphatase-1. Chem. Biol. 16, 365-371 (2009).
37. J. H. Connor, D. C. Weiser, S. Li, J. M. Hallenbeck, S. Shenolikar, Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol. Cell. Biol. 21, 6841-6850 (2001).
38. M. Eto, T. Kitazawa, D. L. Brautigan, Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proc. Natl. Acad. Sci. U.S.A. 101, 8888-8893 (2004).
39. M. Eto, E. Elliott, T.D. Prickett, D. L. Brautigan, Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation. J. Biol. Chem. 277, 44013-44020 (2002).
40. B. Lesage, M. Beullens, L. Pedelini, M. A. Garcia-Gimeno, E. Waelkens, P. Sanz, M. Bollen, A complex of catalytically inactive protein phosphatase-1 sandwiched between Sds22 and inhibitor-3. Biochemistry 46, 8909-8919 (2007).
41. M. Eto, Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J. Biol. Chem. 284, 35273-35277 (2009).
42. F. Puntoni, E. Villa-Moruzzi, Phosphorylation of protein phosphatase-1 isoforms by cdc2-cyclin B in vitro. Mol. Cell. Biochem. 171, 115-120 (1997).
43. J. Q. Wu, J. Y. Guo, W. Tang, C. S. Yang, C. D. Freel, C. Chen, A. C. Nairn, S. Kornbluth, PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation. Nat. Cell Biol. 11, 644-651 (2009).
44. S. Daniel, S. Zhang, A. A. DePaoli-Roach, K. H. Kim, Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J. Biol. Chem. 271, 14692-14697 (1996).
45. Y. Zhang, M. Liao, M. L. Dufau, Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release. J. Biol. Chem. 283, 24039-24046 (2008).
46. L. Trinkle-Mulcahy, A. I. Lamond, Mitotic phosphatases: No longer silent partners. Curr. Opin. Cell Biol. 18, 623-631 (2006).
47. D. Bennett, Transcriptional control by chromosome-associated protein phosphatase-1. Biochem. Soc. Trans. 33, 1444-1446 (2005).
48. K. Koshibu, J. Graff, M. Beullens, F. D. Heitz, D. Berchtold, H. Russig, M. Farinelli, M. Bollen, I. M. Mansuy, Protein phosphatase 1 regulates the histone code for long-term memory. J. Neurosci. 29, 13079-13089 (2009).
49. S. C. Galasinski, K. A. Resing, J. A. Goodrich, N. G. Ahn, Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J. Biol. Chem. 277, 19618-19626 (2002).
50. C. Guo, J. Mi, D. L. Brautigan, J. M. Larner, ATM regulates ionizing radiation-induced disruption of HDAC1:PP1:Rb complexes. Cell. Signal. 19, 504-510 (2007).
51. J. D. Arroyo, W. C. Hahn, Involvement of PP2A in viral and cellular transformation. Oncogene 24, 7746-7755 (2005).
52. 2/M arrest and cell death by blocking protein phosphatase 2A activity regulated by the B55 subunit. J. Virol. 83, 8340-8352 (2009).
53. M. C. Mumby, G. Walter, Protein phosphatases and DNA tumor viruses: Transformation through the back door? Cell Regul. 2, 589-598 (1991).
54. D. Pim, P. Massimi, S. M. Dilworth, L. Banks, Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene 24, 7830-7838 (2005).
55. T. Ammosova, M. Jerebtsova, M. Beullens, B. Lesage, A. Jackson, F. Kashanchi, W. Southerland, V. R. Gordeuk, M. Bollen, S. Nekhai, Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. J. Biol. Chem. 280, 36364-36371 (2005).
56. 134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 94, 843-848 (1997).
57. M. Blanchet, C. Sureau, Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J. Virol. 80, 11935-11945 (2006).
58. S. Emiliani, W. Fischle, C. Van Lint, Y. Al-Abed, E. Verdin, Characterization of a human RPD3 ortholog, HDAC3. Proc. Natl. Acad. Sci. U.S.A. 95, 2795-2800 (1998).
59. I. du Chéné, E. Basyuk, Y. L. Lin, R. Triboulet, A. Knezevich, C. Chable-Bessia, C. Mettling, V. Baillat, J. Reynes, P. Corbeau, E. Bertrand, A. Marcello, S. Emiliani, R. Kiernan, M. Benkirane, Suv39H1 and HP1g are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J. 26, 424-435 (2007).
60. K. Kitatani, J. Idkowiak-Baldys, J. Bielawski, T. A. Taha, R. W. Jenkins, C. E. Senkal, B. Ogretmen, L. M. Obeid, Y. A. Hannun, Protein kinase C-induced activation of a ceramide/protein phosphatase 1 pathway leading to dephosphorylation of p38 MAPK. J. Biol. Chem. 281, 36793-36802 (2006).
61. K. E. Fox, D. M. Fankell, P. F. Erickson, S. M. Majka, J. T. Crossno Jr., D. J. Klemm, Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) α, C/EBP β, or PPARγ2. J. Biol. Chem. 281, 40341-40353 (2006).
62. W. G. Kaelin Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, E. K. Flemington, Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70, 351-364 (1992).
63. S. Cairo, C. Armengol, A. De Reyniès, Y. Wei, E. Thomas, C. A. Renard, A. Goga, A. Balakrishnan, M. Semeraro, L. Gresh, M. Pontoglio, H. Strick-Marchand, F. Levillayer, Y. Nouet, D. Rickman, F. Gauthier, S. Branchereau, L. Brugières, V. Laithier, R. Bouvier, F. Boman, G. Basso, J. F. Michiels, P. Hofman, F. Arbez-Gindre, H. Jouan, M.C.Rousselet-Chapeau, D.Berrebi, L. Marcellin, F. Plenat, D. Zachar, M. Joubert, J. Selves, D. Pasquier, P. Bioulac-Sage, M. Grotzer, M. Childs, M. Fabre, M. A. Buendia, Hepatic stem-like phenotype and interplay of Wnt/β-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14, 471-484 (2008).
64. J. Summers, P. M. Smith, A. L. Horwich, Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64, 2819-2824 (1990).
65. S. F. Wieland, H. C. Spangenberg, R. Thimme, R. H. Purcell, F. V. Chisari, Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc. Natl. Acad. Sci. U.S.A. 101, 2129-2134 (2004).
66. C. Borel, O. Schorr, I. Durand, F. Zoulim, A. Kay, C. Trepo, O. Hantz, Initial amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of embryonic duck hepatocytes is increased by cell cycle progression. Hepatology 34, 168-179 (2001).